More on GALE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders

Upcoming Events

- Earnings (3/17/15 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Galena Biopharma (NQ:GALE)
Delayed: 1.57 -0.05 (3.09%)
Trade Now!
Previous Close $1.62    52 Week High $7.77 
Open $1.60    52 Week Low $1.51 
Day High $1.62    P/E N/A 
Day Low $1.57    EPS $-0.37 
Volume 1,918,084       

Friends, Peers and Foes (?): RDY, PBYI, CYTR, NKTR, PTLA (more...)

Dec 11, 2014 08:38 AM Galena Biopharma (GALE) Presents Initial IHC Screening Data from NeuVax Phase 3 PRESENT
Dec 11, 2014 08:35 AM Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Sympo
Dec 8, 2014 02:23 PM Galena's (GALE) GALE-401 More Promising Following Presentation Phase 2 Data at ASH - Roth
Dec 8, 2014 09:28 AM Pre-Open Stock Movers 12/08: (CBST) (BLRX) (EBAY) Higher; (MYCC) (TASR) (MCD) Lower (more...)
Dec 8, 2014 07:07 AM Galena Biopharma (GALE) Presents Phase 1, Prelim. Phase 2 GALE-401 Data at ASH
Dec 8, 2014 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 8, 2014 07:05 AM Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 5, 2014 07:06 AM Galena Biopharma (GALE) Will Present IHC Data from NeuVax Phase 3 PRESENT at SABCS
Dec 5, 2014 07:05 AM Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)
Dec 5, 2014 07:05 AM Galena Biopharma to Present HER2 Screening Data From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)
View All Articles